Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 39, 2022 - Issue 7
Submit an article Journal homepage
229
Views
1
CrossRef citations to date
0
Altmetric
Articles

Clinical Profile and Outcomes of Primary Immunodeficiency and Malignancy in Childhood at a Tertiary Oncology Center in Developing Country

Derya Özyörüka Division of Pediatric Hematology and Oncology, Health Science University, Ankara City Hospital, Ankara, TurkeyCorrespondence[email protected]
,
Zeliha Güzelküçükb Division of Pediatric Hematology and Oncology, Ankara Children’s Hematology and Oncology Education and Research Hospital, Ankara, Turkey
,
Ayse Metinc Division of Pediatric Immunology, Health Science University, Ankara City Hospital, Ankara, Turkey
,
Suna Emirb Division of Pediatric Hematology and Oncology, Ankara Children’s Hematology and Oncology Education and Research Hospital, Ankara, Turkey
,
Arzu Yazal Erdema Division of Pediatric Hematology and Oncology, Health Science University, Ankara City Hospital, Ankara, Turkey
,
Dilek Kacarb Division of Pediatric Hematology and Oncology, Ankara Children’s Hematology and Oncology Education and Research Hospital, Ankara, Turkey
,
Ayca Koca Yozgatb Division of Pediatric Hematology and Oncology, Ankara Children’s Hematology and Oncology Education and Research Hospital, Ankara, Turkey
,
Can Baris Akerb Division of Pediatric Hematology and Oncology, Ankara Children’s Hematology and Oncology Education and Research Hospital, Ankara, Turkey
,
Selma Çakmakçıd Division of Pediatric Hematology and Oncology, Abdurrahman Yurtaslan Oncology Education and Research Hospital, Ankara, Turkey
,
Sonay Incesoy Özdemire Division of Pediatric Hematology and Oncology, Yıldırım Beyazit University, Ankara City Hospital, Ankara, Turkey
,
Neriman Saria Division of Pediatric Hematology and Oncology, Health Science University, Ankara City Hospital, Ankara, Turkey
,
Meriç Kaymak Cihand Division of Pediatric Hematology and Oncology, Abdurrahman Yurtaslan Oncology Education and Research Hospital, Ankara, Turkey
,
Namık Yasar Özbeka Division of Pediatric Hematology and Oncology, Health Science University, Ankara City Hospital, Ankara, Turkey
&
İnci Ergürhan İlhana Division of Pediatric Hematology and Oncology, Health Science University, Ankara City Hospital, Ankara, Turkey
 show all
Pages 600-612 | Received 06 Jul 2021, Accepted 16 Feb 2022, Published online: 12 Mar 2022

References

  • Kebudi R, Kiykim A, Sahin MK. Primary immunodeficiency and cancer in children; A review of the literature. Curr Pediatr Rev. 2019;15(4):245–250. 019. doi:10.2174/1573396315666190917154058.
  • Hauck F, Voss R, Urban C, Seidel MG. Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders. J Allergy Clin Immunol. 2018;141(1):59–68. doi:10.1016/j.jaci.2017.06.009.
  • Mortaz E, Tabarsi P, Mansouri D, et al. Cancers related to immunodeficiencies: Update and perspectives. Front Immunol. 2016; 365:1–13.
  • Varan A, Büyükpamukçu M, Ersoy F, et al. Malignant solid tumors associated with congenital immunodeficiency disorders. Pediatr Hematol Oncol. 2004;21(5):441–451. doi:10.1080/08880010490457231.
  • Emir S, Vezir E, Azkur D, Demir HA, Metin A. Characteristics of children with non-Hodgkin lymphoma associated with primary immune deficiency diseases: Descriptions of five patients. Pediatr Hematol Oncol. 2013;30(6):544–553. doi:10.3109/08880018.2013.792893.
  • Kiykim A, Eker N, Surekli O, et al. Malignancy and lymphoid proliferation in primary immune deficiencies; hard to define, hard to treat. Pediatr Blood Cancer. 2020;67(2):1–8. doi:10.1002/pbc.28091.
  • Wu J, Zhong W, Yin Y, Zhang H. Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center. BMC Pediatr. 2019;19(1):410–417. doi:10.1186/s12887-019-1729-7.
  • Tanyildiz HG, Dincaslan H, Yavuz G, et al. Lymphoma secondary to congenital and acquired immunodeficiency syndromes at a Turkish Pediatric Oncology Center. J Clin Immunol. 2016;36(7):667–676. doi:10.1007/s10875-016-0324-z.
  • Van der Werff Ten Bosch J, van den Akker M. Genetic predisposition and hematopoietic malignancies in children: Primary immunodeficiency. Eur J Med Genet. 2016;59(12):647–653. doi:10.1016/j.ejmg.2016.03.001.
  • Sánchez-Ramón S, Bermúdez A, González-Granado LI, ID-Signal Onco-Haematology Group, et al. Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs. Front Immunol. 2019;10:586–594.
  • Duan L, Grunebaum E. Hematological malignancies associated with primary immunodeficiency disorders. Clin Immunol. 2018;194:46–59. doi:10.1016/j.clim.2018.06.011.
  • Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK. Immunodeficiency-associated lymphomas. Blood Rev. 2008;22(5):261–281. doi:10.1016/j.blre.2008.03.009.
  • Rothblum-Oviatt C, Wright J, Lefton-Greif MA, et al. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11(1):159–180. doi:10.1186/s13023-016-0543-7.
  • Salavoura K, Kolialexi A, Tsangaris G, Mavrou A. Development of cancer in patients with primary immunodeficiencies. Anticancer Res. 2008;28(2B):1263–1269.
  • Derpoorter C, Bordon V, Laureys G, Haerynck F, Lammens T. Genes at the crossroad of primary immunodeficiencies and cancer. Front Immunol. 2018;9:2544.
  • Chandrakasan S, Chandra S, Davila Saldana BJ, Torgerson TR, Buchbinder D. Primary immune regulatory disorders for the pediatric hematologist and oncologist: A case-based review. Pediatr Blood Cancer. 2019;66(5):e27619. doi:10.1002/pbc.27619.
  • Shabbat S, Aharoni J, Sarid L, Ben-Harush M, Kapelushnik J. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma. Pediatr Blood Cancer. 2009;52(5):664–666. doi:10.1002/pbc.21808.
  • Sulit DJ, L Tom WL, Willert JR, Nespeca MP, Friedlandler FS. Multicentric infantile hemangiopericytoma: case report and review of the literature. Pediatr Hematol Oncol. 2011; 33:166–170.
  • Bertero L, Anfossi V, Osella-Abate S, et al. Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series. PLoS One. 2018;13(9):e0203570 5doi:10.1371/journal.pone.0203570.
  • Somekh I, Marquardt B, Liu Y, et al. Novel mutations in RASGRP1 are associated with immunodeficiency, immune dysregulation, and EBV-induced lymphoma. J Clin Immunol. 2018;38(6):699–710. doi:10.1007/s10875-018-0533-8.
  • Van Montfrans JM, Hoepelman AIM, Sigrid Otto S, et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol. 2012;129(3):787–793. doi:10.1016/j.jaci.2011.11.013.
  • Daria D, Filippi MD, Knudsen ES, et al. The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress. Blood. 2008;111(4):1894–1890. 15doi:10.1182/blood-2007-02-071746.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.